Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of Tsc2-Null Cells
Rheb is a small GTPase member of the Ras superfamily and an activator of mTORC1, a protein complex master regulator of cell metabolism, growth, and proliferation. Rheb/mTORC1 pathway is hyperactivated in proliferative diseases, such as Tuberous Sclerosis Complex syndrome and cancer. Therefore, targe...
Main Authors: | Marisol Estrella Armijo, Emilia Escalona, Daniela Peña, Alejandro Farias, Violeta Morin, Matthias Baumann, Bert Matthias Klebl, Roxana Pincheira, Ariel Fernando Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.912688/full |
Similar Items
-
Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
by: Raef Shams, et al.
Published: (2021-08-01) -
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
by: Polina Kosillo, et al.
Published: (2022-07-01) -
Lysosomal Regulation of mTORC1 by Amino Acids in Mammalian Cells
by: Yao Yao, et al.
Published: (2017-07-01) -
Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
by: Wenxing Chen, et al.
Published: (2017-01-01) -
Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase
by: Natasha Emmanuel, et al.
Published: (2017-06-01)